Evidence map›Paper›PMID 39688688›Full record

ArticleDermatologie (Heidelberg, Germany)2025

[Comprehensive training in psychodermatology: the diploma course of the European Society for Dermatology and Psychiatry].

Sandra Hanneken, Francoise Poot

Abstract readEnglish Abstract
PubMed Publisher
In one paragraph

Article in Dermatologie (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sandra HannekenPraxis Empoderm, Graf-Adolf-Str. 59, 40210, Düsseldorf, Deutschland. praxis@dr-hanneken.de.
Francoise PootDepartment Dermatology, HUB - Erasme Hospital, Brüssel, Belgien.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPsychodermatological conditions play an important role in dermatological practice. The biopsychosocial disease model is of central significance.

objectivePsychodermatological knowledge is underrepresented in specialist training and medical care. There is a need for continuing education offers for primary psychodermatological disorders as well as for skin diseases related to psychological stress. MATERIALS AND

methodsThe work comprises a description of the structure, organization, and content of the diploma course offered by the European Society for Dermatology and Psychiatry (ESDaP), along with a personal conclusion after completing the course.

resultsContinuing education in the diagnosis and treatment of psychodermatological disorders should be an integral part of dermatology training. The ESDaP diploma course conveys knowledge regarding psychosomatic dermatology and dermatopsychiatry. The target audience includes dermatologists, psychologists, psychiatrists, and psychotherapists in training and practice. The two-level course offers foundational knowledge for those working with psychodermatological patients in level 1, while level 2 allows for advanced specialization. Additional requirements for obtaining the diploma include case presentations, lectures, and multiple-choice examinations.

conclusionPsychological factors are common in dermatological patients and require effective and holistic management. The ESDaP diploma course provides in-depth knowledge and fosters skills in patient care and physician-patient communication.

Indexed as

DermatologyEducation, Medical, ContinuingPsychiatryPsychophysiologic DisordersPsychosomatic MedicineSkin DiseasesCurriculumEuropeHumansSocieties, MedicalBiopsychosocialDisease copingPhysician-patient relationsPsychosomatic dermatologyStress, psychological

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.